Video Shorts

1:19
Supplemental Oxygen Is Not the End of an Active Life
2 days ago
by
Mike Hess, MPH

1:11
Breakthrough: New Molecule Targets Liver Fat & Weight Loss
2 days ago
by
Sean Wharton, MD, PharmD

1:21
A Paradigm Shift in Pediatric Heart Treatment
3 days ago
by
Joseph Rossano, MD, MS

1:15
43% Lower Risk of Hypoglycemia? The Data Explained
5 days ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:49
Atacicept 2-Year Data for IgAN
5 days ago
by
Sayna Norouzi, MD

1:26
Is Medicine a Field Worth Pursuing for Young People?
6 days ago
by
Andrea Murina, MD(+1 more)

1:00
FDA's Recent Psychedelic Hearing: Key Takeaways
8 days ago
by
Sarah Norman, MPP

1:14
Transforming Diabetes Treatment: Reducing 14 Injections to Just 1
9 days ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:00
Is the Science Settled on the Link Between Wildfire Smoke and Allergies?
9 days ago
by
Jim Blando, PhD(+1 more)

1:00
Patient Advocate on Topical Steroid Withdrawal: Why Clinicians Should Stay Curious
10 days ago
by
Briana Banos

0:54
Environmental Triggers of Inflammatory Bowel Disease
10 days ago
by
Elizabeth Spencer, MD, MS

1:00
Psychedelic Research Challenges with Multidrug Placebo
12 days ago
by
Josh D. Woolley, MD, PhD

0:58
Add-on ALIS Cuts MACLD Recurrence Rates
12 days ago
by
Jakko Van Ingen, MD, PhD

0:41
Are Oral Treatments Changing Psoriasis Care?
13 days ago
by
Raj Chovatiya, MD, PhD

1:00
The Ethics of "Incomplete Disclosure" in Psychedelic Placebo-Controlled Trials
14 days ago
by
Josh D. Woolley, MD, PhD

1:00
CKM Guidelines Guide Clinicians Through Critical Metabolic Risk Factors
16 days ago
by
Heather Johnson, MD

1:04
The Hidden Reason Patients Skip Kidney Screenings
16 days ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:06
Why Non-Surgical Alternatives Like PDT Are Essential for Dermatology
16 days ago
by
Neal Bhatia, MD

0:46
Tozorakimab Cuts COPD Exacerbations Across Eosinophil Levels
17 days ago
by
Frank C. Sciurba, MD

0:42
Wildfire Smoke Linked to Atopic Dermatitis Flares
18 days ago
by
Wynne Armand, MD

0:53
Overcoming the Complexity Paradox in Heart Failure Treatment
18 days ago
by
John Ostrominski, MD

1:18
No Phone Needed: The Mint Insulin Patch Pump
19 days ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:10
Why Dupilumab Beats Omalizumab in Asthma Treatment
20 days ago
by
Guy Brusselle, MD, PhD

1:02
The 'Non-Specific' Symptoms Causing Rare Disease Delays
20 days ago
by
Gaia Coppock, MD

1:20
How Lipid Lowering Makes You More Resilient
21 days ago
by
Robert P. Giugliano, MD

1:07
Choosing the Right IL-23 Treatment for Psoriatic Disease
23 days ago
by
David Oberlin, MD

0:46
Are All IL-23 Agents for Psoriatic Disease Created Equal?
24 days ago
by
David Oberlin, MD

0:53
Using Machine Learning to Personalize Patient Outreach
25 days ago
by
Ankeet Bhatt, MD, MBA

1:06
Wildfire Smoke's Delayed Impact: Allergies a Year Later?
25 days ago
by
Jim Blando, PhD
Advertisement
Advertisement
Trending on HCPLive
1
EADV Congress 2026: Day 3 Recap—5 Headlines to Know
2
EADV 2026: Telikibart Attains EASI-75 in 70% at Week 16 in Atopic Dermatitis
3
AMETHYST: Litifilimab Sustains CLE Gains at 52 Weeks, With Victoria Werth, MD
4
Upadacitinib Tops Nemolizumab on Skin, Itch Targets in Indirect Analysis
5

